The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)

AIM: To identify responders to continuous glucose monitoring (CGM) in relation to reductions in HbA1c and percentage of time spent in hypoglycaemia after initiation of CGM for individuals with type 1 diabetes treated with multiple daily insulin injections. MATERIALS AND METHODS: We analysed data fro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Ólafsdóttir, Arndís F., Bolinder, Jan, Heise, Tim, Polonsky, William, Ekelund, Magnus, Wijkman, Magnus, Pivodic, Aldina, Ahlén, Elsa, Schwarcz, Erik, Nyström, Thomas, Hellman, Jarl, Hirsch, Irl B., Lind, Marcus
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839699/
https://ncbi.nlm.nih.gov/pubmed/33200487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14257
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados